Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia

References

• De WiedDSiglingHONeuropeptides involved in the pathophysiology of schizophrenia and major depressionNeurotox Res2002445346812754159
   PubMed Web of Science ®Google Scholar
• KreamRMStefanoGBPtáčekRPsychiatric implications of endogenous morphine: up-to-date reviewFolia Biol2010566231241
   Web of Science ®Google Scholar
• StefanoGBGoumonYCasaresFEndogenous morphineTrends Neurosci20002343644210941194
   PubMed Web of Science ®Google Scholar
• FricchioneGLMendozaAStefanoGBMorphine and its psychiatric implicationsAdv Neuroimmunol1994421171317952828
   PubMed Web of Science ®Google Scholar
• LipskaBKWeinbergerDRDelayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the ratBrain Res Dev Brain Res199315752132227903225
   PubMedGoogle Scholar
• NeriCGhelardiniCSotakBDopamine is necessary to endogenous morphine formation in mammalian brain in vivoJ Neurochem20081062337234418643791
   PubMed Web of Science ®Google Scholar
• StefanoGBKreamREndogenous opiates, opioids, and immune function: evolutionary brokerage of defensive behaviorsSemin Cancer Biol20081819019818191410
   PubMed Web of Science ®Google Scholar
• VolavkaJDavisLGEhrlichYHEndorphins, dopamine, and schizophreniaSchizophr Bull19795222723937595
   PubMed Web of Science ®Google Scholar
• KlineNSLiCHLehmannHELajthaALaskiECooperTBeta-endorphin – induced changes in schizophrenic and depressed patientsArch Gen Psychiatry19773411111113901140
   PubMed Web of Science ®Google Scholar
• GernerRHCatlinDHGorelickDAHuiKKLiCHbeta-Endorphin. Intravenous infusion causes behavioral change in psychiatric inpatientsArch Gen Psychiatry19803766426477387336
   PubMed Web of Science ®Google Scholar
• WagemakerHCadeRThe use of hemodialysis in chronic schizophreniaAm J Psychiatry1977134684685869035
   PubMed Web of Science ®Google Scholar
• PalmourRErvinFWagemakerHCadeRCharacterization of a peptide derived from the serum of psychiatric patientsUsdinEBunneyWEJrKlineNSEndorphins in Mental Health ResearchNew YorkMacmillan1979581593
   Google Scholar
• EmrichHMKisslingWFischlerMZerssenDFRiedhammerHEdelHHHemodialysis in schizophrenia: three failures with chronic patientsAm J Psychiatry19791361095464144
   PubMed Web of Science ®Google Scholar
• DomschkeWDickschasAMitzneggPC.S.F. beta-endorphin in schizophreniaLancet197912102486731
   PubMed Web of Science ®Google Scholar
• GunneLMLindstromLTereniusLNaloxone-induced reversal of schizophrenic hallucinationsJ Neural Transm1977401319319204
   PubMed Web of Science ®Google Scholar
• PickarDVartanianFBunneyWEShort-term naloxone administration in schizophrenic and manic patients: a World Health Organization Collaborative StudyArch Gen Psychiatry19823933136121545
   PubMed Web of Science ®Google Scholar
• JanowskyDSSegalDSBloomFAbramsAGuilleminRLack of effect of naloxone on schizophrenic symptomsAm J Psychiatry1977134926927879360
   PubMed Web of Science ®Google Scholar
• BloomFSegalDLingNGuilleminRProfound behavioral effects in rats suggest new etiological factors in mental illnessScience1976194630632185694
   PubMed Web of Science ®Google Scholar
• Van RossumDHanischUKQuirionRNeuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptorsNeurosci Biobehav Rev1997216496789353797
   PubMed Web of Science ®Google Scholar
• DrumhellerAMenardDFournierAJolicoeurFBNeurochemical effects of CGRPAnn NY Acad Sci1992306575465481637121
   PubMed Web of Science ®Google Scholar
• ClementiGGrassiMValerioCPratoAFioreCEDragoFEffects of calcitonin gene-related peptide on extrapyramidal motor systemPharmacol Biochem Behav1992425455481409789
   PubMed Web of Science ®Google Scholar
• MathéAAAgrenHLindströmLTheodorssonEIncreased concentration of calcitonin gene-related peptide in cerebrospinal fluid of depressed patients. A possible trait marker of major depressive disorderNeurosci Lett199451821381427715797
   PubMed Web of Science ®Google Scholar
• MathéAAAgrenHWallinABlennowKCalcitonin gene-related peptide and calcitonin in the CSF of patients with dementia and depression: possible disease markersProg Neuropsychopharmacol Biol Psychiatry200226414811853117
   PubMed Web of Science ®Google Scholar
• KaySRPositive and negative syndromes in schizophreniaVan PraagHClinical and Experimental Psychiatric. Monograph 5New YorkBrunnel/Mazer1991
   Google Scholar
• MathéAAHertelSPNomikosGGGruberPASMathéEJMThe psychotomimetic drugs D-amphetamine and phencyclidine release calcitonin gene related peptide in the limbic forebrain of the ratJ Neurosci Res1996463163238933370
   PubMed Web of Science ®Google Scholar
• GruberSHMMathéAAEffects of amphetamine and dopamine receptor antagonists on calcitonin gene-related peptide, neuropeptide Y and neurotensin in rat brainNeuropsychopharmacology2000232118
   Google Scholar
• GruberSHNomikosGGMathéAADopamine receptor antagonists prevent the d-amphetamine-induced increase in calcitonin gene-related peptide levels in ventral striatumJ Neurosci Res2001156460661111398184
   PubMed Web of Science ®Google Scholar
• AngelucciFGruberSHMathéAAA pilot study of rat brain regional distribution of calcitonin, katacalcin and calcitonin gene-related peptide before and after antipsychotic treatmentNeuropeptides20013528529112030813
   PubMed Web of Science ®Google Scholar
• AngelucciFGruberSHCaltagironeCMathéAADifferential effects of olanzapine, haloperidol and risperidone on calcitonin gene-related peptide in the rat brainNeuropeptides20084253554118662828
   PubMed Web of Science ®Google Scholar
• Laux-BiehlmannAMouheicheJVérièpeJGoumonYEndogenous morphine and its metabolites in mammals: history, synthesis, localization and perspectivesNeuroscience2013132339511723266549
   PubMed Web of Science ®Google Scholar
• MauriMCRudelliRVanniSCholecystokinin, beta-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controlsPsychiatry Res1998201–245509579701
   PubMed Web of Science ®Google Scholar
• PanzaGMonzaniESacerdotePPenatiGPaneraiAEBeta-endorphin, vasoactive intestinal peptide and cholecystokinin in peripheral blood mononuclear cells from healthy subjects and from drug-free and halo-peridol treated schizophrenic patientsActa Psychiatr Scand1992852072101561892
   PubMed Web of Science ®Google Scholar
• PickarDBunneyWEJrDouilletPRepeated naloxone administration in schizophrenia: a phase II World Health Organization StudyBiol Psychiatry1989254404482539206
   PubMed Web of Science ®Google Scholar
• RapaportMHWolkowitzOKelsoeJRPatoCKonickiPEPickarDBeneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patientsNeuropsychopharmacology1993921111158105790
   PubMed Web of Science ®Google Scholar
• Gil-AdIDickermanZAmdurskySLaronZDiurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compared to control subjectsPsychopharmacology1986884964992939487
   PubMed Web of Science ®Google Scholar